Angiotensin
converting enzyme 2 (ACE2) plays a key role in renin–angiotensin
system regulation and amino acid homeostasis. Human ACE2 acts as the
receptor for severe acute respiratory syndrome coronaviruses SARS-CoV
and SARS-CoV-2. ACE2 is also widely expressed in epithelial cells
of the lungs, heart, kidney, and pancreas. It is considered an important
drug target for treating SARS-CoV-2 as well as pulmonary diseases,
heart failure, hypertension, renal diseases, and diabetes. Despite
the critical importance, the mechanism of ligand binding to the human
ACE2 receptor remains unknown. Here, we have addressed this challenge
through all-atom simulations using a novel ligand Gaussian accelerated
molecular dynamics (LiGaMD) method. Microsecond time scale LiGaMD
simulations have unprecedentedly captured multiple times of spontaneous
binding and unbinding of a potent inhibitor MLN-4760 in the ACE2 receptor.
With ligand far away in the unbound state, the ACE2 receptor samples
distinct Open, Partially Open, Closed, and Fully Closed conformations.
Upon ligand binding to the active site, conformational ensemble of
the ACE2 receptor is biased toward the Closed state as observed in
the X-ray experimental structure. The LiGaMD simulations thus suggest
a conformational selection mechanism for ligand recognition by the
highly flexible ACE2 receptor, which is expected to facilitate rational
drug design targeting human ACE2 against coronaviruses and other related
human diseases.